Health and BiotechLife SciencesPharma
Novel Anti-TB Therapeutics
This project focuses on the development of drugs that target novel, unexplored biological pathways to treat Tuberculosis and tackle the global threat of drug resistant TB.
In the genes - Gene-cell therapies
Duchenne Muscular Dystrophy can devastate a person’s life, resulting in mobility limitation and heart failure. Now, the latest in gene technology is being used to offer targeted therapies to patients in order to bring expertise to this vital area.
Rapid diagnosis for Parkinson’s - SebOMIX Ltd
A non-invasive test for Parkinson’s Disease potentially offering rapid, non-invasive diagnosis before the onset of symptoms.
Robotics for everyone - Puzzlebot
Manchester Robotics have a mission to globalise access to learning and development tools for robotics. In doing so, they intend to close the £96bn/year STEM skills gap in the manufacturing workforce and democratise educational resources for society’s most disruptive technologies: robotics, automation and AI.
Chemistry and Physics
Boiling stones - Zeolites
Zeolites, derived from the Greek words zeo (to boil) and lithos (stone), are aluminosilicate minerals that seemed to froth or boil when heated in a blowpipe in flame. Zeolites are used in many industries due internal pore structure. A novel method has been developed of making zeolites with a tailored porosity in a timely and energy efficient way that also improves its performance in catalysis.
Breathe easy - Clin-e-cal Ltd
Clin-e-cal is a spinout digital health company from The University of Manchester aiming to transform respiratory care.
ComputingEngineering and ManufacturingSoftware
Silence is golden - compact attenuators for use in tight spaces
The University of Manchester have developed a novel approach to noise control, able to decimate decibels and provide unparalleled silence.
Health and BiotechLife SciencesMedtech
Dysphagia treatment - Phagenesis
Invaluable treatment to transform the lives of patients who have difficulty swallowing.
Adept ADAPTations - ADAPT
Providing GPs and patients (who have battled with cancer, and won but now have other health problems as a result) with individualised information about diagnosis, treatment, possible late toxicities and how these can be recognised, mitigated and managed.
Energy and EnvironmentEngineering and Manufacturing
A virtuous circle - NovaCrack
NovaCrack is a rapid depolymerisation process that transforms mixed plastic waste into high-value hydrocarbons which can be converted back to virgin polymers, thereby closing the loop for a truly circular economy.
Health and BiotechLife SciencesPharma
Vaccination innovation – Novel virus-like particle platform
A novel virus-like particle platform which could transform vaccine antigen delivery and gene therapy.
Dental development - Manchester Imaging Ltd
Manchester Imaging Ltd is a successful spinout from The University of Manchester using software solutions to capture cavities and train the next generation of dentists.
Whirlwind development - TornadoVM
TornadoVM: A practical and efficient framework for accelerating managed programming languages on heterogeneous hardware accelerators
Crystal clear - CrystalGrower
CrystalGrower is a tool to develop a greater understanding of how crystals grow at the nanoscale through simulation of crystal habit and surface topography that, in turn, helps predict and control functionality.
University robotics technologies
The University of Manchester are developing innovative robotic solutions to carry out inspections and maintenance underground, underwater, and in confined spaces.
Advanced MaterialsEnergy and EnvironmentEngineering and Manufacturing
This innovative technology offers a green solution to the plastic industry through the development of never-been-done-before materials.
Hyper-realistic display images - Revised colour mapping
With an upgrade on the industry-standard trichromatic colour space, The University of Manchester have revised colour mapping to improve image quality and transform the palate of visual image creation.
Targeted cancer therapy - ManTRa DX
ManTRa DX have developed tumour-site-specific gene expression signatures to assess hypoxia which has the potential to deliver major advances in personalised cancer medicine.
Stop bugging me! - Antimicrobial peptides
Addressing concerns regarding super-resistant diseases which even the strongest medicines cannot touch, this peptide-packed technology is a remedy for the post-antibiotic age.
Currently, the only licenced therapy for ischaemic stroke remains largely unsuitable for many due to patients being naturally resistant to the treatment. As a result, there remains an urgent need for an accurate alternative for this vital treatment.